BioBlog

In this week’s Innovation Partners BioBlog, we share highlights from the world of healthcare. In Texas, a judge deemed the ACA unconstitutional since the individual mandate has dropped to $0. The Cigna/ExpressScripts merger clears another hurdle, and Democrats seek to push forward a bill to block

An interesting article in the New York Times invited experts to weigh in on how to cut drug prices without compromising innovation. It’s worth a read and brings up many of the challenges facing the industry. Competition among retail pharmacies finds Walgreens partnering with FedEx to offer same-day

This week’s Innovation Partners BioBlog focuses on the business of healthcare. The CVS-Aetna merger is complete, and experts are watching eagerly to see how the company uses the CVS chain for its planned community-based healthcare initiatives. The FDA has approved a new biosimilar, Rituxan, and

In this week’s Innovation Partners BioBlog, we feature updates on many important stories from the world of healthcare. The FDA is reviewing their 40-year old fast-track process with the goal of updating it to improve medical device safety review procedures. Small, independent hospitals have found a

What lowers costs without compromising the quality of care or value? That's the theme of this week's Innovation Partners BioBlog. We look at the acquisition of Athenahealth and the shift to Virence's value-based care solutions, how value-based care has lowered the costs of Medicare and the impact of

In this week's Innovation Partners BioBlog, we share the news that Medicaid won expansion in three states; Montana was the holdout among the four states allowing voters to choose expansion. CMS modified its proposed code changes in responses to an outcry from physicians groups concerned that the

This week, attention focuses on several aspects of Medicare. CMS will delay modifications to E/M codes until 2021 thanks in large part to push back from doctors. Site-neutral payments are in the news related to Medicare along with Medicare Part B. In other news, CVS plans some testing of new

In this week’s Innovation Partners BioBlog, we look at the challenges of designing new payment models for prescription drugs. The president seeks to align United States’ drug costs with those of its European counterparts; he also signed legislation this week to combat the opioid crisis. The